Apellis Pharmaceuticals, Inc. (APLS)

21.80 -0.32 (-1.47%) USD  |  NASDAQ  |  Feb 25, 09:35
More

Apellis Pharmaceuticals Liability on Credit Line (Quarterly)

Liability on Credit Line (Quarterly) Chart

View Liability on Credit Line (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Liability on Credit Line (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Liability on Credit Line (Quarterly) Range, Past 5 Years

View Liability on Credit Line (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Liability on Credit Line (Quarterly) Benchmarks

View Liability on Credit Line (Quarterly) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --
Amicus Therapeutics, Inc. --
Ionis Pharmaceuticals, Inc. --
Sarepta Therapeutics, Inc. --